Changes in nationwide Medicare and Medicaid expenditures on lipid-lowering therapies after proprotein convertase/subtilisin type 9 inhibitor availability

Buckley, LF; Ting, C; Fatani, N; Fanikos, J

Buckley, LF (corresponding author), Brigham & Womens Hosp, Dept Pharm Serv, 75 Francis St, Boston, MA 02115 USA.

JOURNAL OF CLINICAL LIPIDOLOGY, 2020; 14 (3): 315

Abstract

BACKGROUND: Several advances in lipid-lowering pharmacotherapy and changes in generic formulation availability occurred between 2013 and 2017. OBJECTI......

Full Text Link